There are 1105 resources available
TIL therapy: 2024 landmark approval year and clinical potential in solid tumours
Presenter: John Haanen
Session: Cell and gene therapy for solid tumours: Coming to a bedside near you soon?
Resources:
Slides
Webcast
Bispecific antibodies in multiple myeloma
Presenter: Yunxin Chen
Session: Bispecific antibodies
Resources:
Slides
Webcast
27O - Assessment of overall survival benefit from neoadjuvant chemotherapy in elderly HER-2 negative breast cancer patients: A population-based study
Presenter: Wenjie Lv
Session: Proffered Paper session: Breast cancer
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session: Thoracic malignancies
Resources:
Webcast
Q&A and discussion
Session: Proffered Paper session: Developmental and precision medicine
Resources:
Webcast
Future development of immunotherapy in GI cancers
Presenter: Feng Wang
Session: Incorporating immunotherapy in gastrointestinal (GI) cancer
Resources:
Slides
Webcast
Interactive discussion: Cell and gene therapy for solid tumours – What’s hot, what’s hype and what’s not.
Session: Cell and gene therapy for solid tumours: Coming to a bedside near you soon?
Resources:
Webcast
Q&A and discussion
Session: Bispecific antibodies
Resources:
Webcast
2O - Analysis of Asian and non-Asian patients (pts) from the NATALEE trial of ribociclib (RIB) + a nonsteroidal aromatase inhibitor (NSAI) in pts with HR+/HER2− early breast cancer (EBC)
Presenter: Yen-Shen Lu
Session: Proffered Paper session: Breast cancer
Resources:
Abstract
Slides
Webcast
478O - Updated results of oral PD-L1 inhibitor ABSK043 in advanced solid tumor patients (pts) from a phase I study
Presenter: Shun Lu
Session: Proffered Paper session: Developmental and precision medicine
Resources:
Abstract